PMH33 the Cost-Effectiveness of Paliperidone ER in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy106 - Cost-Effectiveness of Rare Diseases in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Paliperidone ER: A Review of the Clinical Trial Data

Neuropsychiatric Disease and Treatment
2008English

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia

Psychiatric Services
MedicinePsychiatryMental Health
2016English

PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Cost-Effectiveness of Alternative Smoking Cessation Scenarios in Spain: Results From the EQUIPTMOD

Addiction
MedicinePsychiatryMental Health
2018English

PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Decision Analytic Economic Paliperidone ER in Relapsing Schizophrenic Patients in Italy

Farmeconomia. Health economics and therapeutic pathways
2008English

Cost-Effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain

Journal of Health Economics and Outcomes Research
2017English

Pms51 - Cost-Effectiveness of Tofacitinib-Containing Sequences for Rheumatoid Arthritis Patients in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy